These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
629 related articles for article (PubMed ID: 22084578)
21. L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences. Fujigaki H; Yamamoto Y; Saito K Neuropharmacology; 2017 Jan; 112(Pt B):264-274. PubMed ID: 26767951 [TBL] [Abstract][Full Text] [Related]
22. The role of kynurenines in the pathomechanism of amyotrophic lateral sclerosis and multiple sclerosis: therapeutic implications. Füvesi J; Rajda C; Bencsik K; Toldi J; Vécsei L J Neural Transm (Vienna); 2012 Feb; 119(2):225-34. PubMed ID: 22258797 [TBL] [Abstract][Full Text] [Related]
23. The Influence of Kynurenine Metabolites on Neurodegenerative Pathologies. Pathak S; Nadar R; Kim S; Liu K; Govindarajulu M; Cook P; Watts Alexander CS; Dhanasekaran M; Moore T Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255925 [TBL] [Abstract][Full Text] [Related]
24. Endogenous neurotoxins from tryptophan. Stone TW Toxicon; 2001 Jan; 39(1):61-73. PubMed ID: 10936623 [TBL] [Abstract][Full Text] [Related]
25. Microorganisms, Tryptophan Metabolism, and Kynurenine Pathway: A Complex Interconnected Loop Influencing Human Health Status. Dehhaghi M; Kazemi Shariat Panahi H; Guillemin GJ Int J Tryptophan Res; 2019; 12():1178646919852996. PubMed ID: 31258331 [TBL] [Abstract][Full Text] [Related]
27. Longitudinal associations of plasma kynurenines and ratios with anxiety and depression scores in colorectal cancer survivors up to 12 months post-treatment. Holthuijsen DDB; van Roekel EH; Bours MJL; Ueland PM; Breukink SO; Janssen-Heijnen MLG; Keulen ETP; Gigic B; Gsur A; Meyer K; Ose J; Ulvik A; Weijenberg MP; Eussen SJPM Psychoneuroendocrinology; 2024 May; 163():106981. PubMed ID: 38335827 [TBL] [Abstract][Full Text] [Related]
28. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation. Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923 [TBL] [Abstract][Full Text] [Related]
29. Vitamins B2 and B6 as determinants of kynurenines and related markers of interferon-γ-mediated immune activation in the community-based Hordaland Health Study. Theofylaktopoulou D; Ulvik A; Midttun Ø; Ueland PM; Vollset SE; Nygård O; Hustad S; Tell GS; Eussen SJ Br J Nutr; 2014 Oct; 112(7):1065-72. PubMed ID: 25105221 [TBL] [Abstract][Full Text] [Related]
30. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. Sas K; Robotka H; Toldi J; Vécsei L J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670 [TBL] [Abstract][Full Text] [Related]
31. Relationship of tryptophan metabolites with the type and severity of multiple sclerosis. Isık SMT; Onmaz DE; Ekmekci AH; Ozturk S; Unlu A; Abusoglu S Mult Scler Relat Disord; 2023 Sep; 77():104898. PubMed ID: 37481818 [TBL] [Abstract][Full Text] [Related]
33. Kynurenine and its metabolites in Alzheimer's disease patients. Gulaj E; Pawlak K; Bien B; Pawlak D Adv Med Sci; 2010; 55(2):204-11. PubMed ID: 20639188 [TBL] [Abstract][Full Text] [Related]